Renaissance Technologies LLC just provided an update on share ownership of Ligand Pharmaceuticals Incorporated

Renaissance Technologies LLC just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Renaissance Technologies LLC claims to own 1,480,819 shares. This represents 6.97% of Ligand Pharmaceuticals Incorporated.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!

Other recent filings from the company include the following:

Ligand Pharmaceuticals: Ligand Reports Second Quarter 2020 Financial Results - Aug. 3, 2020
Ligand Pharmaceuticals Incorporated's Chief Executive Officer just picked up 4,315 shares - July 9, 2020

Auto Refresh